| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.869 | 0.004 | 0.879 | Caspase 9 stimulant | 0.879 0.004 CID_154699568 | CID_154699568 | |
| 0.84 | 0.004 | 0.866 | Free radical scavenger | 0.866 0.003 CID_154699568 | CID_154699568 | |
| 0.817 | 0.004 | 0.898 | Antioxidant | 0.898 0.004 CID_154699568 | CID_154699568 | |
| 0.803 | 0.006 | 0.803 | 15-Lipoxygenase inhibitor | |||
| 0.796 | 0.004 | 0.796 | 12-Lipoxygenase inhibitor | |||
| 0.783 | 0.002 | 0.783 | Peroxidase inhibitor | 0.304 0.037 CID_154699568 | ||
| 0.793 | 0.017 | 0.802 | Apoptosis agonist | 0.802 0.016 CID_154699568 | CID_154699568 | |
| 0.754 | 0.002 | 0.754 | Cystathionine beta-synthase inhibitor | 0.736 0.002 CID_154699568 | ||
| 0.73 | 0.006 | 0.73 | Aldehyde oxidase inhibitor | 0.155 0.134 CID_154699568 | ||
| 0.708 | 0.005 | 0.861 | Histamine release inhibitor | 0.861 0.003 CID_154699568 | CID_154699568 | |
| 0.685 | 0.004 | 0.685 | Superoxide dismutase inhibitor | 0.194 0.124 CID_154699568 | ||
| 0.689 | 0.009 | 0.689 | Aryl hydrocarbon receptor agonist | 0.211 0.097 CID_154699568 | ||
| 0.691 | 0.035 | 0.918 | Alpha-glucosidase inhibitor | 0.918 0.005 CID_154699568 | CID_154699568 | |
| 0.653 | 0.007 | 0.653 | Lipoxygenase inhibitor | |||
| 0.641 | 0.006 | 0.641 | Amyloid beta aggregation inhibitor | 0.512 0.013 CID_154699568 | ||
| 0.61 | 0.003 | 0.623 | NADPH oxidase inhibitor | 0.623 0.003 CID_154699568 | CID_154699568 | |
| 0.611 | 0.006 | 0.611 | GABA C receptor rho-3 antagonist | |||
| 0.604 | 0.001 | 0.604 | Creatine kinase inhibitor | 0.216 0.008 CID_154699568 | ||
| 0.606 | 0.004 | 0.606 | Interleukin 4 antagonist | 0.309 0.008 CID_154699568 | ||
| 0.594 | 0.008 | 0.647 | Hypoxia-inducible factor 1 alpha inhibitor | 0.647 0.005 CID_154699568 | CID_154699568 | |
| 0.597 | 0.011 | 0.699 | 5 Hydroxytryptamine release inhibitor | 0.699 0.004 CID_154699568 | CID_154699568 | |
| 0.586 | 0.003 | 0.586 | Carbonic anhydrase III inhibitor | 0.357 0.004 CID_154699568 | ||
| 0.585 | 0.004 | 0.635 | NOS3 expression enhancer | 0.635 0.004 CID_154699568 | CID_154699568 | |
| 0.625 | 0.047 | 0.842 | Antiinflammatory | 0.842 0.01 CID_154699568 | CID_154699568 | |
| 0.587 | 0.011 | 0.587 | Caspase 3 stimulant | 0.535 0.016 CID_154699568 | ||
| 0.577 | 0.005 | 0.577 | MAO inhibitor | |||
| 0.566 | 0.004 | 0.566 | MAO A inhibitor | |||
| 0.591 | 0.032 | 0.837 | Transcription factor NF kappa B inhibitor | 0.837 0.011 CID_154699568 | CID_154699568 | |
| 0.557 | 0.014 | 0.648 | Apoptosis antagonist | 0.648 0.005 CID_154699568 | CID_154699568 | |
| 0.546 | 0.003 | 0.794 | Xanthine oxidase inhibitor | 0.794 0.002 CID_154699568 | CID_154699568 | |
| 0.536 | 0.006 | 0.536 | Pyruvate kinase inhibitor | 0.289 0.051 CID_154699568 | ||
| 0.527 | 0.007 | 0.845 | Monophenol monooxygenase inhibitor | 0.845 0.003 CID_154699568 | CID_154699568 | |
| 0.55 | 0.032 | 0.55 | Prostaglandin dehydrogenase inhibitor | |||
| 0.515 | 0.003 | 0.515 | Carbonic anhydrase VI inhibitor | 0.296 0.006 CID_154699568 | ||
| 0.514 | 0.005 | 0.514 | Breast cancer-resistant protein inhibitor | 0.083 0.076 CID_154699568 | ||
| 0.502 | 0.007 | 0.502 | Dual specificity phosphatase 3 inhibitor | |||
| 0.5 | 0.007 | 0.508 | Topoisomerase II inhibitor | 0.508 0.006 CID_154699568 | CID_154699568 | |
| 0.498 | 0.006 | 0.498 | Dual specificity phosphatase inhibitor | |||
| 0.495 | 0.005 | 0.495 | 5 Hydroxytryptamine uptake stimulant | 0.203 0.145 CID_154699568 | ||
| 0.494 | 0.004 | 0.494 | Telomerase inhibitor | 0.1 0.033 CID_154699568 | ||
| 0.488 | 0.002 | 0.488 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.144 0.02 CID_154699568 | ||
| 0.492 | 0.009 | 0.492 | P-glycoprotein inhibitor | 0.284 0.032 CID_154699568 | ||
| 0.493 | 0.013 | 0.543 | Vasodilator | 0.543 0.009 CID_154699568 | CID_154699568 | |
| 0.506 | 0.026 | 0.506 | 5 Hydroxytryptamine release stimulant | 0.424 0.041 CID_154699568 | ||
| 0.483 | 0.005 | 0.533 | Lipid peroxidase inhibitor | 0.533 0.005 CID_154699568 | CID_154699568 | |
| 0.478 | 0.004 | 0.478 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.36 0.011 CID_154699568 | ||
| 0.476 | 0.003 | 0.661 | Carbonic anhydrase XIII inhibitor | 0.661 0.003 CID_154699568 | CID_154699568 | |
| 0.486 | 0.017 | 0.665 | Nitric oxide antagonist | 0.665 0.007 CID_154699568 | CID_154699568 | |
| 0.47 | 0.007 | 0.782 | Amylase inhibitor | 0.782 0.002 CID_154699568 | CID_154699568 | |
| 0.466 | 0.013 | 0.466 | RNA-directed DNA polymerase inhibitor | 0.38 0.02 CID_154699568 | ||
| 0.455 | 0.004 | 0.455 | Topoisomerase II alpha inhibitor | 0.417 0.004 CID_154699568 | ||
| 0.467 | 0.02 | 0.832 | Vasodilator, coronary | 0.832 0.003 CID_154699568 | CID_154699568 | |
| 0.467 | 0.024 | 0.467 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.448 | 0.006 | 0.548 | DNA methyltransferase I inhibitor | 0.548 0.004 CID_154699568 | CID_154699568 | |
| 0.443 | 0.004 | 0.443 | M18 aspartyl aminopeptidase inhibitor | 0.125 0.067 CID_154699568 | ||
| 0.45 | 0.012 | 0.45 | Transcription factor STAT inhibitor | 0.186 0.159 CID_154699568 | ||
| 0.432 | 0.004 | 0.432 | HIV-1 integrase (3'-Processing) inhibitor | 0.185 0.01 CID_154699568 | ||
| 0.434 | 0.006 | 0.528 | Protein kinase stimulant | 0.528 0.004 CID_154699568 | CID_154699568 | |
| 0.451 | 0.031 | 0.683 | Spasmolytic | 0.683 0.007 CID_154699568 | CID_154699568 | |
| 0.437 | 0.022 | 0.75 | Hypoglycemic | 0.75 0.004 CID_154699568 | CID_154699568 | |
| 0.421 | 0.008 | 0.421 | Protein-tyrosine phosphatase inhibitor | 0.296 0.02 CID_154699568 | ||
| 0.419 | 0.01 | 0.536 | DNA methylase inhibitor | 0.536 0.005 CID_154699568 | CID_154699568 | |
| 0.406 | 0.007 | 0.406 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.402 | 0.004 | 0.402 | Macrophage migration inhibitory factor inhibitor | 0.071 0.065 CID_154699568 | ||
| 0.407 | 0.013 | 0.641 | Non-steroidal antiinflammatory agent | 0.641 0.004 CID_154699568 | CID_154699568 | |
| 0.395 | 0.008 | 0.395 | MAO B inhibitor | |||
| 0.399 | 0.012 | 0.636 | Melanin inhibitor | 0.636 0.004 CID_154699568 | CID_154699568 | |
| 0.407 | 0.026 | 0.606 | Tumour necrosis factor alpha release inhibitor | 0.606 0.007 CID_154699568 | CID_154699568 | |
| 0.439 | 0.061 | 0.72 | Antibacterial | 0.72 0.007 CID_154699568 | CID_154699568 | |
| 0.4 | 0.028 | 0.617 | Antiamyloidogenic | 0.617 0.007 CID_154699568 | CID_154699568 | |
| 0.377 | 0.008 | 0.377 | Acetylcholinesterase inhibitor | 0.161 0.049 CID_154699568 | ||
| 0.396 | 0.029 | 0.559 | DNA damaging | 0.559 0.01 CID_154699568 | CID_154699568 | |
| 0.371 | 0.004 | 0.371 | HIV-1 integrase (Strand Transfer) inhibitor | 0.157 0.012 CID_154699568 | ||
| 0.37 | 0.006 | 0.37 | 5-Lipoxygenase inhibitor | |||
| 0.37 | 0.007 | 0.37 | Chelator | 0.165 0.031 CID_154699568 | ||
| 0.459 | 0.098 | 0.459 | DNA polymerase beta inhibitor | |||
| 0.362 | 0.005 | 0.362 | Succinate dehydrogenase inhibitor | 0.178 0.069 CID_154699568 | ||
| 0.373 | 0.016 | 0.637 | Hepatoprotectant | 0.637 0.004 CID_154699568 | CID_154699568 | |
| 0.363 | 0.009 | 0.363 | Amyloid beta precursor protein antagonist | |||
| 0.358 | 0.005 | 0.431 | Nitric-oxide synthase stimulant | 0.431 0.003 CID_154699568 | CID_154699568 | |
| 0.448 | 0.098 | 0.448 | DNA directed DNA polymerase inhibitor | 0.219 0.213 CID_154699568 | ||
| 0.339 | 0.003 | 0.339 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.239 0.003 CID_154699568 | ||
| 0.351 | 0.015 | 0.351 | Mcl-1 antagonist | |||
| 0.384 | 0.052 | 0.384 | Streptokinase A inhibitor | |||
| 0.336 | 0.005 | 0.336 | Carbonic anhydrase XV inhibitor | 0.092 0.08 CID_154699568 | ||
| 0.333 | 0.003 | 0.333 | Multidrug resistance-associated protein 1 inhibitor | 0.243 0.005 CID_154699568 | ||
| 0.334 | 0.008 | 0.334 | Protein kinase (CK2) alpha inhibitor | |||
| 0.333 | 0.008 | 0.543 | Alkaline phosphatase inhibitor | 0.543 0.004 CID_154699568 | CID_154699568 | |
| 0.342 | 0.018 | 0.342 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.326 | 0.003 | 0.326 | Xanthine dehydrogenase inhibitor | 0.152 0.007 CID_154699568 | ||
| 0.335 | 0.016 | 0.335 | Tubulin antagonist | |||
| 0.32 | 0.004 | 0.32 | Histone deacetylase SIRT1 stimulant | 0.215 0.005 CID_154699568 | ||
| 0.32 | 0.004 | 0.32 | Histone deacetylase stimulant | 0.215 0.005 CID_154699568 | ||
| 0.328 | 0.012 | 0.363 | Neurotrophic factor enhancer | 0.363 0.008 CID_154699568 | CID_154699568 | |
| 0.318 | 0.005 | 0.318 | Estrogen receptor beta antagonist | 0.094 0.076 CID_154699568 | ||
| 0.346 | 0.036 | 0.346 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.336 | 0.037 | 0.785 | Angiogenesis stimulant | 0.785 0.004 CID_154699568 | CID_154699568 | |
| 0.3 | 0.004 | 0.3 | Aldose reductase inhibitor | 0.287 0.005 CID_154699568 | ||
| 0.357 | 0.062 | 0.777 | Antithrombotic | 0.777 0.005 CID_154699568 | CID_154699568 | |
| 0.297 | 0.011 | 0.297 | Protein-tyrosine phosphatase 1B inhibitor | 0.243 0.018 CID_154699568 | ||
| 0.286 | 0.007 | 0.286 | Estrogen antagonist | 0.128 0.041 CID_154699568 | ||
| 0.284 | 0.005 | 0.284 | Uric acid excretion stimulant | 0.25 0.007 CID_154699568 | ||
| 0.283 | 0.005 | 0.316 | Alcohol dehydrogenase inhibitor | 0.316 0.005 CID_154699568 | CID_154699568 | |
| 0.302 | 0.029 | 0.302 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.274 | 0.004 | 0.274 | CD45 antagonist | 0.046 0.045 CID_154699568 | ||
| 0.302 | 0.033 | 0.467 | Platelet adhesion inhibitor | 0.467 0.007 CID_154699568 | CID_154699568 | |
| 0.315 | 0.047 | 0.315 | Dyrk kinase inhibitor | |||
| 0.287 | 0.021 | 0.287 | Cholinergic | |||
| 0.313 | 0.047 | 0.313 | Transcription factor STAT3 inhibitor | |||
| 0.267 | 0.002 | 0.267 | D-Ala-D-Ala ligase inhibitor | 0.083 0.06 CID_154699568 | ||
| 0.267 | 0.004 | 0.267 | CDC25A inhibitor | 0.115 0.021 CID_154699568 | ||
| 0.267 | 0.005 | 0.267 | Electron transport complex I inhibitor | 0.103 0.075 CID_154699568 | ||
| 0.34 | 0.078 | 0.34 | Vasodilator, peripheral | 0.254 0.124 CID_154699568 | ||
| 0.269 | 0.009 | 0.269 | Protein kinase (CK2) inhibitor | |||
| 0.31 | 0.053 | 0.31 | Insulysin inhibitor | |||
| 0.265 | 0.009 | 0.265 | GABA C receptor rho-2 antagonist | |||
| 0.342 | 0.091 | 0.534 | Immunosuppressant | 0.534 0.024 CID_154699568 | CID_154699568 | |
| 0.255 | 0.007 | 0.255 | Protein kinase C zeta inhibitor | |||
| 0.266 | 0.02 | 0.266 | Cytokine production inhibitor | |||
| 0.326 | 0.082 | 0.326 | Thyroid hormone antagonist | |||
| 0.254 | 0.014 | 0.254 | Butyrylcholinesterase inhibitor | |||
| 0.24 | 0.002 | 0.24 | Dopamine D5 agonist | |||
| 0.261 | 0.027 | 0.261 | Tumour necrosis factor antagonist | |||
| 0.234 | 0.004 | 0.234 | Heat shock protein 70 antagonist | 0.228 0.004 CID_154699568 | ||
| 0.242 | 0.014 | 0.261 | Mannose-6-phosphate isomerase inhibitor | 0.261 0.01 CID_154699568 | CID_154699568 | |
| 0.25 | 0.025 | 0.25 | Phospholipase C inhibitor | 0.207 0.039 CID_154699568 | ||
| 0.251 | 0.026 | 0.251 | Heat shock protein 90 alpha antagonist | |||
| 0.231 | 0.007 | 0.231 | Aromatase inhibitor | |||
| 0.23 | 0.008 | 0.345 | Photosensitizer | 0.345 0.004 CID_154699568 | CID_154699568 | |
| 0.224 | 0.004 | 0.224 | Fatty acid synthase inhibitor | 0.131 0.005 CID_154699568 | ||
| 0.237 | 0.019 | 0.349 | Topoisomerase I inhibitor | 0.349 0.008 CID_154699568 | CID_154699568 | |
| 0.304 | 0.086 | 0.304 | Thyroid hormone beta antagonist | |||
| 0.22 | 0.004 | 0.22 | CDC25B inhibitor | 0.074 0.034 CID_154699568 | ||
| 0.219 | 0.004 | 0.219 | Carbonic anhydrase VII inhibitor | 0.161 0.005 CID_154699568 | ||
| 0.229 | 0.014 | 0.229 | Toll-Like receptor 2 antagonist | 0.129 0.069 CID_154699568 | ||
| 0.222 | 0.007 | 0.222 | Estrogen receptor alpha antagonist | |||
| 0.236 | 0.022 | 0.32 | Insulin secretagoues | 0.32 0.01 CID_154699568 | CID_154699568 | |
| 0.237 | 0.025 | 0.237 | Heat shock protein 90 antagonist | |||
| 0.214 | 0.005 | 0.214 | DOPA decarboxylase inhibitor | |||
| 0.218 | 0.011 | 0.683 | Beta glucuronidase inhibitor | 0.683 0.002 CID_154699568 | CID_154699568 | |
| 0.212 | 0.006 | 0.212 | Transcription factor STAT6 inhibitor | |||
| 0.21 | 0.005 | 0.21 | Myeloperoxidase inhibitor | |||
| 0.21 | 0.006 | 0.21 | Carbonic anhydrase V inhibitor | |||
| 0.212 | 0.009 | 0.212 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.225 | 0.026 | 0.225 | Cyclooxygenase 1 inhibitor | 0.168 0.049 CID_154699568 | ||
| 0.254 | 0.058 | 0.254 | Antimitotic | |||
| 0.216 | 0.02 | 0.216 | Arachidonic acid antagonist | 0.157 0.08 CID_154699568 | ||
| 0.238 | 0.042 | 0.238 | Insulin sensitizer | 0.225 0.051 CID_154699568 | ||
| 0.217 | 0.024 | 0.241 | Aldehyde dehydrogenase inhibitor | 0.241 0.019 CID_154699568 | CID_154699568 | |
| 0.197 | 0.008 | 0.197 | T cell inhibitor | 0.185 0.008 CID_154699568 | ||
| 0.222 | 0.033 | 0.222 | Cyclooxygenase inhibitor | 0.222 0.034 CID_154699568 | ||
| 0.192 | 0.005 | 0.192 | HIV-1 integrase inhibitor | 0.104 0.023 CID_154699568 | ||
| 0.197 | 0.011 | 0.453 | AMP-activated protein kinase stimulant | 0.453 0.004 CID_154699568 | CID_154699568 | |
| 0.184 | 0.006 | 0.184 | Carbonic anhydrase VA inhibitor | |||
| 0.321 | 0.145 | 0.812 | Cyclophilin D inhibitor | 0.812 0.006 CID_154699568 | CID_154699568 | |
| 0.179 | 0.005 | 0.179 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.191 | 0.018 | 0.191 | Adenylate cyclase stimulant | 0.148 0.066 CID_154699568 | ||
| 0.194 | 0.021 | 0.527 | Cyclooxygenase 3 inhibitor | 0.527 0.003 CID_154699568 | CID_154699568 | |
| 0.206 | 0.034 | 0.206 | Bone formation stimulant | 0.148 0.06 CID_154699568 | ||
| 0.186 | 0.014 | 0.186 | Papain-like protease (SARS coronavirus) inhibitor | 0.111 0.109 CID_154699568 | ||
| 0.199 | 0.035 | 0.199 | Death-associated protein kinase 2 inhibitor | |||
| 0.272 | 0.11 | 0.542 | Cholesterol antagonist | 0.542 0.026 CID_154699568 | CID_154699568 | |
| 0.174 | 0.011 | 0.174 | CYP2A6 inhibitor | |||
| 0.172 | 0.01 | 0.172 | Estrogen agonist | 0.131 0.013 CID_154699568 | ||
| 0.176 | 0.014 | 0.176 | Urease inhibitor | |||
| 0.167 | 0.007 | 0.167 | Thioredoxin reductase inhibitor | 0.087 0.047 CID_154699568 | ||
| 0.212 | 0.053 | 0.212 | Histone acetyltransferase inhibitor | |||
| 0.162 | 0.004 | 0.162 | Catechol O-methyltransferase inhibitor | 0.03 0.028 CID_154699568 | ||
| 0.191 | 0.033 | 0.195 | Cyclooxygenase 2 inhibitor | 0.195 0.032 CID_154699568 | CID_154699568 | |
| 0.198 | 0.041 | 0.374 | Interferon gamma antagonist | 0.374 0.012 CID_154699568 | CID_154699568 | |
| 0.164 | 0.011 | 0.164 | Cyclin B3 inhibitor | |||
| 0.189 | 0.037 | 0.535 | Hemostatic | 0.535 0.004 CID_154699568 | CID_154699568 | |
| 0.167 | 0.019 | 0.355 | DNA repair enzyme inhibitor | 0.355 0.004 CID_154699568 | CID_154699568 | |
| 0.152 | 0.005 | 0.152 | Aryl hydrocarbon receptor antagonist | |||
| 0.149 | 0.007 | 0.149 | Estrogen receptor beta agonist | 0.087 0.013 CID_154699568 | ||
| 0.159 | 0.018 | 0.159 | GABA C receptor rho-1 antagonist | |||
| 0.195 | 0.054 | 0.195 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.164 | 0.023 | 0.164 | Potassium channel (Ca-activated) activator | |||
| 0.158 | 0.02 | 0.158 | Androgen antagonist | |||
| 0.175 | 0.043 | 0.281 | Alpha-N-acetylglucosaminidase inhibitor | 0.281 0.018 CID_154699568 | CID_154699568 | |
| 0.207 | 0.08 | 0.207 | Interleukin antagonist | 0.15 0.118 CID_154699568 | ||
| 0.153 | 0.028 | 0.153 | GABA C receptor antagonist | |||
| 0.127 | 0.004 | 0.127 | Glutamate (mGluR7) antagonist | |||
| 0.128 | 0.006 | 0.128 | Topoisomerase II beta inhibitor | 0.12 0.007 CID_154699568 | ||
| 0.127 | 0.006 | 0.228 | Carbonic anhydrase XIV inhibitor | 0.228 0.004 CID_154699568 | CID_154699568 | |
| 0.194 | 0.073 | 0.194 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.14 | 0.02 | 0.167 | Thioredoxin inhibitor | 0.167 0.013 CID_154699568 | CID_154699568 | |
| 0.154 | 0.034 | 0.154 | Ca2+-transporting ATPase inhibitor | 0.149 0.044 CID_154699568 | ||
| 0.151 | 0.032 | 0.151 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.148 | 0.029 | 0.333 | UDP-glucose 4-epimerase inhibitor | 0.333 0.009 CID_154699568 | CID_154699568 | |
| 0.133 | 0.015 | 0.264 | Carbonic anhydrase XII inhibitor | 0.264 0.005 CID_154699568 | CID_154699568 | |
| 0.13 | 0.015 | 0.13 | Beta tubulin antagonist | |||
| 0.137 | 0.022 | 0.137 | Histidine decarboxylase inhibitor | |||
| 0.142 | 0.032 | 0.427 | Mediator release inhibitor | 0.427 0.005 CID_154699568 | CID_154699568 | |
| 0.116 | 0.007 | 0.116 | Heat shock protein 90 beta antagonist | |||
| 0.125 | 0.016 | 0.125 | Lipase inhibitor | 0.079 0.044 CID_154699568 | ||
| 0.279 | 0.175 | 0.279 | Calcium channel L-type activator | |||
| 0.116 | 0.013 | 0.116 | Alpha tubulin antagonist | |||
| 0.113 | 0.013 | 0.113 | Carbonic anhydrase VB inhibitor | |||
| 0.139 | 0.039 | 0.161 | Mucolytic | 0.161 0.027 CID_154699568 | CID_154699568 | |
| 0.121 | 0.023 | 0.121 | Interleukin 5 antagonist | 0.117 0.026 CID_154699568 | ||
| 0.116 | 0.019 | 0.116 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.145 | 0.049 | 0.145 | Adenylate cyclase inhibitor | 0.104 0.081 CID_154699568 | ||
| 0.269 | 0.174 | 0.269 | Transcription factor inhibitor | |||
| 0.115 | 0.02 | 0.115 | mTOR complex 2 inhibitor | |||
| 0.12 | 0.026 | 0.12 | Ornithine decarboxylase inhibitor | 0.097 0.047 CID_154699568 | ||
| 0.13 | 0.036 | 0.287 | Antineoplastic antibiotic | 0.287 0.01 CID_154699568 | CID_154699568 | |
| 0.142 | 0.049 | 0.142 | Cholesterol synthesis inhibitor | 0.111 0.074 CID_154699568 | ||
| 0.181 | 0.089 | 0.181 | I kappa B kinase epsilon inhibitor | |||
| 0.107 | 0.015 | 0.107 | Protein kinase C eta inhibitor | 0.049 0.045 CID_154699568 | ||
| 0.134 | 0.043 | 0.451 | Expectorant | 0.451 0.004 CID_154699568 | CID_154699568 | |
| 0.141 | 0.052 | 0.302 | Alkylator | 0.302 0.012 CID_154699568 | CID_154699568 | |
| 0.093 | 0.005 | 0.093 | Ryanodine receptor antagonist | |||
| 0.111 | 0.024 | 0.111 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.117 | 0.03 | 0.213 | NADH dehydrogenase inhibitor | 0.213 0.009 CID_154699568 | CID_154699568 | |
| 0.132 | 0.046 | 0.132 | TRPA1 agonist | |||
| 0.125 | 0.039 | 0.185 | Toll-Like receptor 4 antagonist | 0.185 0.009 CID_154699568 | CID_154699568 | |
| 0.111 | 0.025 | 0.111 | Keratolytic | |||
| 0.094 | 0.009 | 0.094 | Estrogen receptor alpha agonist | |||
| 0.089 | 0.004 | 0.089 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.121 | 0.038 | 0.121 | Anabolic | |||
| 0.092 | 0.009 | 0.092 | Transcription factor RelA inhibitor | |||
| 0.123 | 0.04 | 0.123 | Pim-1 kinase inhibitor | |||
| 0.108 | 0.025 | 0.108 | Glutamate decarboxylase inhibitor | |||
| 0.113 | 0.031 | 0.113 | Porphobilinogen synthase inhibitor | |||
| 0.206 | 0.124 | 0.206 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.127 | 0.045 | 0.127 | GABA C receptor agonist | |||
| 0.1 | 0.018 | 0.1 | Alcohol oxidase inhibitor | |||
| 0.202 | 0.12 | 0.368 | DNA synthesis inhibitor | 0.368 0.027 CID_154699568 | CID_154699568 | |
| 0.085 | 0.004 | 0.085 | Protein kinase (CK2) beta inhibitor | |||
| 0.097 | 0.016 | 0.119 | Neuraminidase inhibitor | 0.119 0.01 CID_154699568 | CID_154699568 | |
| 0.096 | 0.015 | 0.096 | Protease activated receptor antagonist | |||
| 0.102 | 0.021 | 0.102 | Leukotriene antagonist | 0.082 0.031 CID_154699568 | ||
| 0.148 | 0.071 | 0.148 | Thiol protease inhibitor | |||
| 0.083 | 0.006 | 0.083 | GABA B receptor antagonist | |||
| 0.1 | 0.024 | 0.1 | Potassium channel large-conductance Ca-activated activator | |||
| 0.171 | 0.094 | 0.173 | Anesthetic general | 0.173 0.092 CID_154699568 | CID_154699568 | |
| 0.125 | 0.049 | 0.125 | Nav1.5 sodium channel blocker | |||
| 0.112 | 0.037 | 0.112 | ABCA1 expression enhancer | |||
| 0.093 | 0.017 | 0.093 | CDK4/cyclin D1 inhibitor | |||
| 0.151 | 0.077 | 0.391 | Diuretic | 0.391 0.013 CID_154699568 | CID_154699568 | |
| 0.112 | 0.038 | 0.203 | Triose-phosphate isomerase inhibitor | 0.203 0.01 CID_154699568 | CID_154699568 | |
| 0.086 | 0.013 | 0.086 | Sphingosine kinase inhibitor | |||
| 0.099 | 0.026 | 0.099 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.099 | 0.027 | 0.099 | Leukotriene synthesis inhibitor | |||
| 0.171 | 0.099 | 0.208 | Psychostimulant | 0.208 0.075 CID_154699568 | CID_154699568 | |
| 0.159 | 0.087 | 0.301 | ATPase inhibitor | 0.301 0.006 CID_154699568 | CID_154699568 | |
| 0.097 | 0.029 | 0.097 | Dopamine agonist | |||
| 0.088 | 0.021 | 0.135 | Neuraminidase (influenza) inhibitor | 0.135 0.009 CID_154699568 | CID_154699568 | |
| 0.079 | 0.012 | 0.079 | Potassium channel Kv1.3 blocker | |||
| 0.076 | 0.01 | 0.076 | CXC chemokine 1 receptor antagonist | |||
| 0.122 | 0.056 | 0.185 | DNA intercalator | 0.185 0.03 CID_154699568 | CID_154699568 | |
| 0.145 | 0.079 | 0.145 | Phospholipase A2 inhibitor | |||
| 0.11 | 0.046 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.178 | 0.114 | 0.359 | Cyclic AMP phosphodiesterase inhibitor | 0.359 0.024 CID_154699568 | CID_154699568 | |
| 0.071 | 0.008 | 0.071 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.109 | 0.047 | 0.109 | Prolactin inhibitor | |||
| 0.07 | 0.008 | 0.131 | Arginase inhibitor | 0.131 0.003 CID_154699568 | CID_154699568 | |
| 0.094 | 0.032 | 0.094 | Estrogen-related receptor beta agonist | |||
| 0.099 | 0.038 | 0.099 | Glutathione S-transferase inhibitor | |||
| 0.096 | 0.035 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.13 0.011 CID_154699568 | CID_154699568 | |
| 0.083 | 0.023 | 0.083 | Purinergic P2X1 antagonist | |||
| 0.071 | 0.013 | 0.071 | Squalene epoxidase inhibitor | |||
| 0.087 | 0.03 | 0.087 | Dopamine D1 antagonist | |||
| 0.103 | 0.046 | 0.15 | Phosphodiesterase 6D inhibitor | 0.15 0.009 CID_154699568 | CID_154699568 | |
| 0.121 | 0.064 | 0.121 | Proteasome inhibitor | |||
| 0.068 | 0.012 | 0.068 | DNA-dependent protein kinase inhibitor | |||
| 0.079 | 0.024 | 0.079 | Beta 3 adrenoreceptor antagonist | |||
| 0.069 | 0.015 | 0.069 | Leukotriene C antagonist | |||
| 0.132 | 0.077 | 0.132 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.062 | 0.009 | 0.062 | Sirtuin 2 inhibitor | |||
| 0.1 | 0.048 | 0.1 | Bile acid receptor antagonist | |||
| 0.105 | 0.054 | 0.105 | Sphingomyelinase inhibitor | |||
| 0.102 | 0.051 | 0.214 | Interleukin 12 antagonist | 0.214 0.005 CID_154699568 | CID_154699568 | |
| 0.077 | 0.026 | 0.097 | Maillard reaction inhibitor | 0.097 0.018 CID_154699568 | CID_154699568 | |
| 0.084 | 0.035 | 0.084 | MAP kinase kinase 7 inhibitor | |||
| 0.087 | 0.038 | 0.087 | GABA aminotransferase inhibitor | 0.083 0.042 CID_154699568 | ||
| 0.181 | 0.132 | 0.547 | Immunostimulant | 0.547 0.023 CID_154699568 | CID_154699568 | |
| 0.085 | 0.037 | 0.085 | Adenosine A3 receptor antagonist | |||
| 0.052 | 0.004 | 0.052 | Dopamine D1 agonist | 0.036 0.006 CID_154699568 | ||
| 0.076 | 0.029 | 0.076 | Glutamate (mGluR6) antagonist | |||
| 0.067 | 0.02 | 0.067 | Dihydroorotate oxidase inhibitor | |||
| 0.21 | 0.163 | 0.21 | Thioredoxin glutathione reductase inhibitor | |||
| 0.08 | 0.035 | 0.103 | Carbonic anhydrase inhibitor | 0.103 0.026 CID_154699568 | CID_154699568 | |
| 0.064 | 0.02 | 0.118 | Glucose-6-phosphate translocase inhibitor | 0.118 0.004 CID_154699568 | CID_154699568 | |
| 0.129 | 0.084 | 0.129 | Farnesoid X receptor antagonist | |||
| 0.061 | 0.019 | 0.061 | Dopamine D5 antagonist | |||
| 0.065 | 0.023 | 0.101 | Leukotriene B4 antagonist | 0.101 0.01 CID_154699568 | CID_154699568 | |
| 0.099 | 0.059 | 0.099 | CDK2/cyclin A inhibitor | |||
| 0.087 | 0.047 | 0.087 | Caspase 7 inhibitor | |||
| 0.136 | 0.096 | 0.136 | MAP kinase kinase 4 inhibitor | |||
| 0.092 | 0.053 | 0.092 | Calcium antagonist | |||
| 0.071 | 0.032 | 0.097 | Carbonic anhydrase IX inhibitor | 0.097 0.021 CID_154699568 | CID_154699568 | |
| 0.057 | 0.019 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.064 | 0.026 | 0.064 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.111 | 0.076 | 0.17 | DNA polymerase I inhibitor | 0.17 0.039 CID_154699568 | CID_154699568 | |
| 0.258 | 0.224 | 0.258 | MAP kinase 1 inhibitor | |||
| 0.076 | 0.043 | 0.162 | Phosphofructokinase-1 inhibitor | 0.162 0.016 CID_154699568 | CID_154699568 | |
| 0.127 | 0.094 | 0.127 | Cytidine deaminase inhibitor | |||
| 0.041 | 0.009 | 0.041 | Estrone sulfatase inhibitor | |||
| 0.104 | 0.072 | 0.104 | 5 Hydroxytryptamine 3A agonist | |||
| 0.054 | 0.023 | 0.054 | Adenylate cyclase 1 inhibitor | |||
| 0.109 | 0.079 | 0.109 | Interleukin 8 antagonist | |||
| 0.099 | 0.069 | 0.099 | Adenylate kinase inhibitor | |||
| 0.107 | 0.078 | 0.143 | Microtubule formation inhibitor | 0.143 0.042 CID_154699568 | CID_154699568 | |
| 0.051 | 0.024 | 0.051 | Purinergic P2X4 antagonist | |||
| 0.053 | 0.027 | 0.053 | Adenosine deaminase inhibitor | |||
| 0.039 | 0.012 | 0.039 | Estrogen-related receptor beta antagonist | |||
| 0.082 | 0.055 | 0.082 | Opioid kappa receptor antagonist | |||
| 0.043 | 0.017 | 0.043 | Vanilloid 3 antagonist | |||
| 0.047 | 0.022 | 0.047 | Liver X receptor alpha agonist | |||
| 0.13 | 0.105 | 0.249 | Hexokinase inhibitor | 0.249 0.017 CID_154699568 | CID_154699568 | |
| 0.038 | 0.014 | 0.038 | ATP citrate lysase inhibitor | |||
| 0.071 | 0.047 | 0.071 | Protein kinase C beta inhibitor | |||
| 0.075 | 0.052 | 0.075 | GABA B receptor agonist | |||
| 0.045 | 0.023 | 0.045 | Sphingosine kinase 1 inhibitor | |||
| 0.061 | 0.038 | 0.061 | Bcl-xL inhibitor | |||
| 0.05 | 0.029 | 0.068 | Glucose-6-phosphate isomerase inhibitor | 0.068 0.013 CID_154699568 | CID_154699568 | |
| 0.041 | 0.021 | 0.041 | Leukotriene C4 antagonist | |||
| 0.066 | 0.045 | 0.066 | Beta adrenoreceptor antagonist | |||
| 0.04 | 0.023 | 0.04 | Glutamate (mGluR8) agonist | |||
| 0.055 | 0.038 | 0.055 | Cyclin B2 inhibitor | |||
| 0.066 | 0.049 | 0.066 | Sirtuin 1 inhibitor | |||
| 0.072 | 0.056 | 0.101 | Phosphodiesterase VI inhibitor | 0.101 0.019 CID_154699568 | CID_154699568 | |
| 0.112 | 0.095 | 0.112 | Antibacterial (Helicobacter pylori) | |||
| 0.139 | 0.123 | 0.139 | Lipocortins synthesis antagonist | |||
| 0.058 | 0.042 | 0.058 | CDK4/cyclin D inhibitor | |||
| 0.081 | 0.065 | 0.081 | Histamine N-methyltransferase inhibitor | |||
| 0.131 | 0.116 | 0.131 | CF transmembrane conductance regulator agonist | |||
| 0.141 | 0.127 | 0.141 | Neurotensin receptor agonist | |||
| 0.05 | 0.037 | 0.05 | Beta 2 adrenoreceptor antagonist | |||
| 0.125 | 0.112 | 0.125 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.115 | 0.102 | 0.115 | Vanilloid 1 agonist | 0.112 0.108 CID_154699568 | ||
| 0.05 | 0.038 | 0.05 | Aconitate hydratase inhibitor | |||
| 0.101 | 0.088 | 0.134 | Beta amyloid protein antagonist | 0.134 0.053 CID_154699568 | CID_154699568 | |
| 0.047 | 0.035 | 0.047 | Cholesterol esterase inhibitor | |||
| 0.059 | 0.048 | 0.059 | Heme oxygenase stimulant | |||
| 0.059 | 0.047 | 0.061 | Transcription factor AP-1 inhibitor | 0.061 0.044 CID_154699568 | CID_154699568 | |
| 0.042 | 0.032 | 0.042 | Nerve growth factor antagonist | |||
| 0.032 | 0.022 | 0.032 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.109 | 0.099 | 0.109 | Toll-Like receptor 9 antagonist | |||
| 0.024 | 0.015 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.038 | 0.029 | 0.038 | Retinoic acid alpha receptor agonist | |||
| 0.041 | 0.032 | 0.041 | Carbonic anhydrase IV inhibitor | |||
| 0.023 | 0.014 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.04 | 0.034 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.055 | 0.05 | 0.055 | Cyclin B1 inhibitor | |||
| 0.08 | 0.076 | 0.08 | Potassium channel activator | |||
| 0.207 | 0.204 | 0.207 | Calcium channel activator | |||
| 0.05 | 0.048 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.045 CID_154699568 | CID_154699568 | |
| 0.021 | 0.019 | 0.021 | Dopamine autoreceptor agonist | |||
| 0.054 | 0.053 | 0.054 | NMDA receptor glycine site agonist | |||
| 0.034 | 0.033 | 0.034 | Delayed rectifier potassium channel blocker | |||
| 0.146 | 0.149 | 0.367 | Platelet antagonist | 0.367 0.034 CID_154699568 | CID_154699568 | |
| 0.048 | 0.051 | 0.139 | Heparanase inhibitor | 0.139 0.003 CID_154699568 | CID_154699568 | |
| 0.017 | 0.02 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 CID_154699568 | CID_154699568 | |
| 0.079 | 0.083 | 0.098 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.098 0.056 CID_154699568 | CID_154699568 | |
| 0.052 | 0.06 | 0.07 | Lipocortins synthesis agonist | 0.07 0.021 CID_154699568 | CID_154699568 | |
| 0.016 | 0.028 | 0.021 | Leukotriene B4 receptor 2 antagonist | 0.021 0.017 CID_154699568 | CID_154699568 | |
| 0.038 | 0.049 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.064 0.01 CID_154699568 | CID_154699568 | |
| 0.013 | 0.025 | 0.019 | Telomerase stimulant | 0.019 0.009 CID_154699568 | CID_154699568 | |
| 0.066 | 0.079 | 0.088 | Interferon agonist | 0.088 0.041 CID_154699568 | CID_154699568 | |
| 0.02 | 0.037 | 0.087 | Sodium/glucose cotransporter 2 inhibitor | 0.087 0.004 CID_154699568 | CID_154699568 | |
| 0.016 | 0.037 | 0.065 | Protein 30S ribosomal subunit inhibitor | 0.065 0.005 CID_154699568 | CID_154699568 | |
| 0.078 | 0.1 | 0.085 | Glutamate release inhibitor | 0.085 0.076 CID_154699568 | CID_154699568 | |
| 0.104 | 0.128 | 0.277 | Cell wall synthesis inhibitor | 0.277 0.012 CID_154699568 | CID_154699568 | |
| 0.019 | 0.045 | 0.073 | Sodium/glucose cotransporter inhibitor | 0.073 0.004 CID_154699568 | CID_154699568 | |
| 0.018 | 0.044 | 0.031 | Vanilloid 2 agonist | 0.031 0.008 CID_154699568 | CID_154699568 | |
| 0.045 | 0.081 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_154699568 | CID_154699568 | |
| 0.038 | 0.077 | 0.049 | Cytokine production stimulant | 0.049 0.032 CID_154699568 | CID_154699568 | |
| 0.137 | 0.178 | 0.285 | Interleukin agonist | 0.285 0.056 CID_154699568 | CID_154699568 | |
| 0.114 | 0.162 | 0.207 | Interleukin 6 antagonist | 0.207 0.037 CID_154699568 | CID_154699568 | |
| 0.047 | 0.1 | 0.06 | Interferon inducer | 0.06 0.054 CID_154699568 | CID_154699568 | |
| 0.091 | 0.145 | 0.365 | Thrombolytic | 0.365 0.015 CID_154699568 | CID_154699568 | |
| 0.065 | 0.12 | 0.149 | Transcription factor NF kappa B stimulant | 0.149 0.016 CID_154699568 | CID_154699568 | |
| 0.055 | 0.114 | 0.088 | Glycine receptor antagonist | 0.088 0.045 CID_154699568 | CID_154699568 | |
| 0.034 | 0.094 | 0.072 | Alpha-mannosidase inhibitor | 0.072 0.016 CID_154699568 | CID_154699568 | |
| 0.056 | 0.124 | 0.163 | Falcipain 2 inhibitor | 0.163 0.023 CID_154699568 | CID_154699568 | |
| 0.037 | 0.105 | 0.056 | Factor III inhibitor | 0.056 0.023 CID_154699568 | CID_154699568 | |
| 0.057 | 0.128 | 0.165 | Falcipain inhibitor | 0.165 0.025 CID_154699568 | CID_154699568 | |
| 0.005 | 0.077 | 0.016 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_154699568 | CID_154699568 | |
| 0.023 | 0.097 | 0.065 | Mannosidase inhibitor | 0.065 0.014 CID_154699568 | CID_154699568 | |
| 0.059 | 0.141 | 0.125 | ATPase (Vacuolar H+) inhibitor | 0.125 0.017 CID_154699568 | CID_154699568 | |
| 0.021 | 0.112 | 0.078 | Antibiotic Aminoglycoside-like | 0.078 0.005 CID_154699568 | CID_154699568 | |
| 0.03 | 0.127 | 0.073 | Nitric oxide donor | 0.073 0.029 CID_154699568 | CID_154699568 | |
| 0.108 | 0.204 | 0.149 | CC chemokine 6 receptor antagonist | 0.149 0.023 CID_154699568 | CID_154699568 | |
| 0.024 | 0.131 | 0.048 | Microtubule stabilization | 0.048 0.031 CID_154699568 | CID_154699568 | |
| 0.126 | 0.279 | 0.389 | Peptidyltransferase inhibitor | 0.389 0.008 CID_154699568 | CID_154699568 | |
| 0.02 | 0.188 | 0.357 | Selectin antagonist | 0.357 0.004 CID_154699568 | CID_154699568 | |
| 0.009 | 0.186 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 CID_154699568 | CID_154699568 | |
| 0.016 | 0.241 | 0.103 | Protein 50S ribosomal subunit inhibitor | 0.103 0.012 CID_154699568 | CID_154699568 | |
| 0.066 | 0.296 | 0.296 | Hypolipemic | 0.296 0.05 CID_154699568 | CID_154699568 | |
| 0.118 | 0.399 | 0.4 | Interleukin 2 agonist | 0.4 0.027 CID_154699568 | CID_154699568 | |
| 0.016 | 0.308 | 0.081 | DNA gyrase inhibitor | 0.081 0.026 CID_154699568 | CID_154699568 | |
| 0.011 | 0.485 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.011 CID_154699568 | CID_154699568 | |
| 0.017 | 0.574 | 0.209 | Anticoagulant | 0.209 0.05 CID_154699568 | CID_154699568 | |
| 0.044 | 0.62 | 0.426 | Immunomodulator | 0.426 0.037 CID_154699568 | CID_154699568 | |
| 0.013 | 0.678 | 0.061 | Factor IXa inhibitor | 0.061 0.026 CID_154699568 | CID_154699568 | |
| 0.011 | 0.766 | 0.211 | Cell adhesion inhibitor | 0.211 0.022 CID_154699568 | CID_154699568 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |